- US-listed companies
- ABBOTT LABORATORIES
- Financials
- Net income margin (%)
ABBOTT LABORATORIESABT
Market cap
$221.4B
P/E ratio
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Dec 31, 2024 | 31.9 | +123.90% |
| Dec 31, 2023 | 14.3 | -10.16% |
| Dec 31, 2022 | 15.9 | -3.25% |
| Dec 31, 2021 | 16.4 | +26.39% |
| Dec 31, 2020 | 13 | +12.39% |
| Dec 31, 2019 | 11.6 | +49.23% |
| Dec 31, 2018 | 7.7 | +344.68% |
| Dec 31, 2017 | 1.7 | -74.06% |
| Dec 31, 2016 | 6.7 | -69.03% |
| Dec 31, 2015 | 21.7 | +92.15% |
| Dec 31, 2014 | 11.3 | -4.32% |
| Dec 31, 2013 | 11.8 | -10.37% |
| Dec 31, 2010 | 13.2 |